← Back to Search

Adaptive Cognitive Control Trainer (ACCT) for Cognitive Impairment (Senior Living Trial)

N/A

Waitlist Available

Led By Joaquin Anguera, Ph.D.

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at baseline and post intervention at the 6 week mark

Awards & highlights

Senior Living Trial Summary

This trial is testing a digital health assessment and remediation program for seniors in assisted living. The goal is to see if it's feasible and to provide evidence for a larger-scale implementation.

Eligible Conditions

Cognitive Impairment
Aging

Senior Living Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at baseline and post intervention at the 6 week mark

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at baseline and post intervention at the 6 week mark

This trial's timeline: 3 weeks for screening, Varies for treatment, and at baseline and post intervention at the 6 week mark for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean Change on Adaptive Cognitive Evaluation (ACE) from Baseline at 6 weeks

Secondary outcome measures

Mean Change on Cognitive Failures Questionnaire (CFQ) from Baseline at 6 weeks

Mean Change on Everyday Cognition Scale (ECog) from Baseline at 6 weeks

Mean Change on General health and well-being (SF-36) from Baseline at 6 weeks

Senior Living Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Adaptive Cognitive Control Trainer (ACCT)Experimental Treatment1 Intervention

There are three modules within the game, each training a different aspect of cognitive control (attention, goal management, working memory): a visual search task for attention abilities, a spatial span task for working memory, and a task switching paradigm for goal management abilities. There are also 3 different levels of difficulty associated with each module; advancing to the next level delivers an advanced challenge that enhances the difficulty in performing the given cognitive task. Participants advance to the next level of difficulty following 6 training sessions occurring over 2 weeks, with the total training experience being 6 weeks of training (3 days/week), with each training session lasting 36 minutes (not including self-paced breaks).

Group II: Active Control GroupActive Control1 Intervention

An active control application will be used for this arm. The total training experience here will also be for 6 weeks (3 days/week), with each training session lasting ~30 minutes (not including self-paced breaks). Here an app that is matched in terms of expectancy of benefits compared to our training groups will be determined by questioning 100 naïve individuals to predict their expected improvement on each cognitive domain across a multitude of possible applications.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Adaptive Cognitive Control Trainer (ACCT)

2021

N/A

~20

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,237,536 Total Patients Enrolled

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,017,044 Total Patients Enrolled

Joaquin Anguera, Ph.D.Principal InvestigatorUC San Francisco

Media Library

Active Control App Clinical Trial Eligibility Overview. Trial Name: NCT04905849 — N/A

Cognitive Impairment Research Study Groups: Adaptive Cognitive Control Trainer (ACCT), Active Control Group

Cognitive Impairment Clinical Trial 2023: Active Control App Highlights & Side Effects. Trial Name: NCT04905849 — N/A

Active Control App 2023 Treatment Timeline for Medical Study. Trial Name: NCT04905849 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies left for patients to join this trial?

"Per information on clinicaltrials.gov, this medical study has concluded its recruitment efforts as of June 6th 2022--the date it was last updated. Despite that, 294 other trials are currently welcoming participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Enhancing Cognitive Control Abilities Using Mobile Technology in a Senior Living Community

2021. "Enhancing Cognitive Control Abilities Using Mobile Technology in a Senior Living Community". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04905849.